Characteristics | Arm A(EV) = 54 | Arm B(PLD/V) = 50 | ||
---|---|---|---|---|
 | No. | % | No. | % |
Age, years | Â | Â | ||
   Median | 63 | 61 | ||
   Range | 27-70 | 35-69 | ||
Pre/Postmenopausal | 10/44 | 9/41 | ||
Median ECOGPS (range) | 1(0-3) | 1(0-3) | ||
*HR status | Â | Â | Â | Â |
   Positive | 39 | 72.2 | 32 | 64.0 |
   Negative | 13 | 24.1 | 15 | 30.0 |
   Unknown | 2 | 3.7 | 3 | 6.0 |
HER-2 status | Â | Â | Â | Â |
   Positive |  |  |  |  |
   Negative |  |  |  |  |
   Unknown |  |  |  |  |
Prior adjuvant chemotherapy** | 20 | 37 | 21 | 42 |
Prior hormonal therapy | Â | Â | Â | Â |
   Adjuvant | 35 | 64.8 | 30 | 60 |
   Advanced | 10 | 18.5 | 11 | 22 |
Disease free-interval (years) | Â | Â | Â | Â |
   < 1 | 10 |  | 11 |  |
   1-5 | 30 |  | 28 |  |
   >5 | 14 |  | 11 |  |
Dominant disease site | Â | Â | Â | Â |
   Viscera | 40 | 74.0 | 32 | 64.0 |
   Bone | 11 | 20.4 | 9 | 18.0 |
   Soft tissue | 3 | 5.6 | 9 | 18.0 |
Number of disease site | Â | Â | Â | Â |
   1 | 23 | 42.6 | 23 | 46.0 |
   2 | 23 | 42.6 | 18 | 36.0 |
   ≥ 3 | 8 | 42.6 | 9 | 18.0 |